持股变动声明
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286 Size: 7 KB 网页链接
简介:CNS Pharmaceuticals, Inc.是一家临床前阶段的制药公司,于2017年7月27日组建为内华达州公司,专注于开发用于治疗脑和中枢神经系统肿瘤的抗癌药物,这些药物基于与HPI的许可协议,以及 与Reata的合作和资产购买协议。
今开:1.98 | 昨收:1.98 |
最高:2.3499 | 最低:1.92 |
涨停价: | 跌停价: |
总市值:1884977 |
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286 Size: 7 KB 网页链接
CNS Pharmaceuticals(CNSP)03-29 05:35
$CNS Pharmaceuticals(CNSP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-24-001829 Act: 34 Size: 517 KB 网页链接
CNS Pharmaceuticals(CNSP)04-10 18:05
$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-002244 Act: 34 Size: 1 MB 网页链接
CNS Pharmaceuticals(CNSP)04-15 18:15
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359 Act: 34 Size: 4 MB 网页链接
CNS Pharmaceuticals(CNSP)06-17 23:25
$CNS Pharmaceuticals(CNSP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-24-004259 Act: 33 Size: 375 KB 网页链接
CNS Pharmaceuticals(CNSP)05-20 18:05
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001574 Act: 33 Size: 1 KB 网页链接
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283 Size: 7 KB 网页链接
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290 Size: 7 KB 网页链接
CNS Pharmaceuticals(CNSP)05-10 05:35
$CNS Pharmaceuticals(CNSP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-24-003171 Act: 33 Size: 1 MB 网页链接
CNS Pharmaceuticals(CNSP)04-11 09:55
$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002285 Size: 7 KB 网页链接
mx在隔壁2023-05-20 05:27
$CNS Pharmaceuticals(CNSP)$ 老妖复活,动力不弱查看全文
韩信超短2023-04-17 22:13
冷枪手假亦真2021-11-17 00:18
产业链观察2021-06-30 05:34
药闻| 2021年6月29日, 专门开发针对脑部原发性和转移性癌症的新疗法和中枢神经系统d的生物制药公司$CNS Pharmaceuticals(CNSP)$ 今天宣布美国食品和药物管理局 (FDA) 为其主要研究药物 Berubicin 授予快速通道指定,用于治疗复发性多形性胶质母细胞瘤 (GBM) 适应症。查看全文
修炼中的Jessie2021-02-10 21:15
赛选几轮后,Mark一下建仓的药股们,剩下的就留给时间吧。$CNS Pharmaceuticals(CNSP)$ $Applied Genetic(AGTC)$ $Surface Oncology(SURF)$ VXRT查看全文
WilAkoto中概垃圾车2021-01-12 06:33
$CNS Pharmaceuticals(CNSP)$ 悄悄地拿根水草查看全文
Linktu2020-12-23 20:57
$CNS Pharmaceuticals(CNSP)$ 挂单1.9博反弹 查看全文
皮神超级欧2020-12-19 04:59
$CNS Pharmaceuticals(CNSP)$ 这走势复刻昨天啊,莫非周一盘前也要暴涨?查看全文
皮神超级欧2020-12-19 00:23
$CNS Pharmaceuticals(CNSP)$ 因为要出门早上设了个3.4就没去管了。虽然盘前到了4.5,但是我不贪心,这周完美收局。查看全文
皮神超级欧2020-12-18 04:54
$CNS Pharmaceuticals(CNSP)$ 2.3补了一仓,2.5清了一半,剩下的留下了过年哈哈哈,别到时候bxrx那样崩了呀查看全文
$CNS Pharmaceuticals(CNSP)$ 8-K/A [Amend] Current report, item 9.01 Accession Number: 0001683168-24-004367 Act: 34 Size: 238 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-24-004259 Act: 33 Size: 375 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001683168-24-004253 Act: 34 Size: 900 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-24-004062 Act: 33 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001683168-24-003998 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001574 Act: 33 Size: 1 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-24-003550 Act: 34 Size: 228 KB 网页链接
$CNS Pharmaceuticals(CNSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-24-003531 Act: 34 Size: 2 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001683168-24-003171 Act: 33 Size: 1 MB 网页链接
$CNS Pharmaceuticals(CNSP)$ 8-K Current report, item 8.01 Accession Number: 0001683168-24-003063 Act: 34 Size: 202 KB 网页链接